Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550366 · ClinicalTrials.gov registry record
Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI
A clinical trial, sponsored by University of Minnesota.
- Terminated
- Registry status
- 44
- Enrollment target
NCT02550366: Clinical Trial study, sponsored by University of Minnesota.
NCT02550366 is a clinical trial that was terminated before completion, run by University of Minnesota. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02550366 was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- 44 participants
- Enrollment target
Study Summary
Coronary artery disease (CAD) is the leading cause of death in the United States. Cardiac MRI is a non-invasive non-ionizing technique for a comprehensive cardiac exam, which can be used in the diagnosis of CAD. In this work, the investigators will develop and validate techniques for accelerated cardiac MRI, offering better volumetric coverage of the heart, improved contrast, and superior spatial and temporal resolutions.
Primary Outcome
vessel length and sharpness
Interventions
- DRUG MRI Contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2024-01-19 |
Why NCT02550366 stopped before completion
NCT02550366 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI Contrast is the first listed.
NCT02550366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02550366 about?
NCT02550366 is a clinical study titled "Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI". Coronary artery disease (CAD) is the leading cause of death in the United States. Cardiac MRI is a non-invasive non-ionizing technique for a comprehensive cardiac exam, which can be used in the diagnosis of CAD. In this work, the investigators will develop and validate techniques for accelerated car...
What is the current status of trial NCT02550366?
This trial is currently terminated. The enrollment target is 44 participants. The study started on 2016-01-01. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT02550366?
The interventions under investigation include: MRI Contrast (DRUG).
Who is sponsoring clinical trial NCT02550366?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI